arrhythmia | GenomeWeb

arrhythmia

This Week in PNAS

In PNAS this week: sequencing approaches to characterize cisplatin-mediated DNA damage, somatic mosaicism in long-QT syndrome case, and more.

The firm will provide in-kind testing for 900 cases in the Sudden Death in the Young registry where the cause of death could not be determined by an autopsy.

This Week in PLOS

In PLOS this week: parent-of-origin effects, framework to uncover clinically important mutations from whole genome sequence data, and more.

NEW YORK (GenomeWeb News) – By combining a meta-analysis with follow-up experiments in two model systems, an international team of researchers uncovered 14 new loci associated with heart rate and homed

By Uduak Grace Thomas
A new computer model of the human heart could help predict side effects of drugs used to treat abnormal heart rhythms, according to its developers.

The companies will study the potential role of galectin-3 in screening patients for cardiac-resynchronization therapy.

The partners are deciding whether to run the multiplex test on a microarray or a sequencing platform. Factors in the decision include the complexity of the test and the technical feasibility of multiplexed, targeted resequencing.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.